Table 1.
Glomerular endothelial cell layer | GBM disorders | Mesangial deposits | Podocytary slit diaphragm disorders | Subendothelial/subepithelial deposit | Others |
ANCA | Primary | IgAN | MYH9 disease | Primary GN | WRN |
Endocapillary | Alport | HSP | Fabry disease | MBP | SCD |
TBMD | Endocapillary | ||||
HANAC | Crescentic | ||||
? LPHS | |||||
Secondary GN | |||||
Secondary | SLE | ||||
Anti-GBM disease | Cryoglobulinemia | ||||
C3 glomerulopathy | |||||
CFHR5 nephropathy | Fibrillar deposit | ||||
Fibronectin | |||||
Fibrillary | |||||
Immunotactoid |
GBM: Glomerular basement membrane; ANCA: Antineutrophil cytoplasmic antibodies; CFHR5: Complement factor H–related 5 nephropathy; GN: Glomerulonephritis; HANAC: Hereditary angiopathy, nephropathy, aneurysms, and muscle cramps syndrome; IgAN: IgA nephropathy; LPHS: Loin back pain syndrome; MBP: Membranoproliferative; SCD: Sickle cell disease; HSP: Henoch-Schönlein purpura; SLE: Systemic lupus erythematous; TBMD: Thin basement membrane disease; WRN: Warfarin related nephropathy.